Description
Key Features
-
Purity: ≥94% average CD34⁺ cell purity after thawing, verified by flow cytometry — outperforming competitor systems like Miltenyi in independent analyses.
-
Viability: ≥91% average post-thaw CD34⁺ viability, ensuring functionality for in vitro and in vivo use.
-
Potency: Yields up to 3× more SCID-repopulating cells per 1M CD34⁺ than competitor vials, as shown in NSG mouse engraftment studies.
-
Sterility: Each lot passes rigorous sterility testing. No microbial contamination has been detected across multiple validation runs.
-
Integrity: TEM imaging confirms healthy morphology — no residual magnetic beads, no membrane disruption, and superior cellular structure vs. Miltenyi-derived cells.
-
Efficiency: FerroBio’s proprietary semi-automated magnetic separation requires minimal manual handling and reduces hands-on processing time by up to 60% compared to traditional methods.
